Xvivo Perfusion (XVIVO.ST) traded down -0.1 % during a 24 hours period ending at 08:05 AM Central Europe on Wednesday 28th. One Xvivo Perfusion stock can currently be bought for about SEK 202 on popular exchanges. Current supply of Xvivo Perfusion stocks is 31.3 mn. Xvivo Perfusion has a current market capitalization of SEK 6.4 bn and approximately SEK 15.9 mn worth of Xvivo Perfusion was traded on exchanges in the last 24 hours. Since last month end, Xvivo Perfusion has traded -15.13 % down. Simple moving average of last 200 days is at SEK 244.11. The highest price of past 52 weeks was recorded at SEK 314.8 on 08/11/2026. 52 weeks low was at SEK 160.1 on 11/18/2025.
Here is how related stocks have performed in the past 24 hours:
Vbg -B (VBG-B.ST) traded down -5.29 % and now trades at SEK 295.5. Current market capitalisation for Vbg -B is SEK 7.4 bn. Current price/earnings ratio for Vbg -B is 17.91.
Gruvaktiebolaget Viscaria (VISC.ST) traded up 1.88 % and now trades at SEK 19.5. Current market capitalisation for Gruvaktiebolaget Viscaria is SEK 7.5 bn.
Sivers Semiconductors (SIVE.ST) traded up 7.79 % and now trades at SEK 22.68. Current market capitalisation for Sivers Semiconductors is SEK 7.5 bn.
Platzer Fastigheter Hold (PLAZ-B.ST) traded flat 0 % and now trades at SEK 61.8. Platzer Fastigheter Hold has a market capitalisation of SEK 7.2 bn. Platzer Fastigheter Hold has a current price to earnings ratio of 8.93.
Investment Oresund (ORES.ST) traded up 0.14 % and now trades at SEK 146.6. Investment Oresund has a market capitalisation of SEK 6.6 bn. Current price/earnings ratio for Investment Oresund is 5.25.
About Xvivo Perfusion
Xvivo Perfusion AB is a medical technology company based in Goteborg, Sweden, that specializes in developing optimized solutions for organ, tissue, and cell preservation in connection with transplantation. These solutions are aimed at revolutionizing the current standard of care in the health care industry by providing innovative equipment and supplies for improved patient outcomes.